Sclareol-Based Pharmacological Applications in Cancer Therapy
Summary
Sclareol is a labdane-type diterpene alcohol extracted from Salvia sclarea (clary sage) that has garnered attention for its multifaceted anticancer properties. Preclinical studies demonstrate that sclareol can inhibit proliferation across a range of tumour cell lines by inducing cell cycle arrest and programmed cell death. Mechanistically, sclareol modulates key signalling pathways involved in apoptosis, including mitochondrial membrane depolarisation and caspase activation, while also generating reactive oxygen species that trigger oxidative stress in malignant cells. In vivo experiments further reveal its capacity to reduce tumour volume and burden in chemical carcinogenesis models, often through upregulation of phase II detoxification enzymes and restoration of antioxidant defences. Beyond monotherapy, sclareol has been investigated as a chemosensitiser, enhancing the efficacy of established cytotoxic agents and overcoming drug resistance. Formulation efforts such as encapsulation in nanoparticles or liposomes have improved its bioavailability and targeted delivery, underscoring its translational potential. Collectively, these findings position sclareol as a promising lead compound for adjunctive or stand-alone cancer therapy, with ongoing work aimed at optimising its pharmacokinetics, safety profile and combination regimens for eventual clinical evaluation.
Research from Nature Portfolio
No recent Nature Portfolio content available.
Sclareol-Based Pharmacological Applications in Cancer Therapy publication trend
The graph below shows the total number of articles in sclareol-based pharmacological applications in cancer therapy across all publications each year (not limited to Nature Index journals).
Technical terms
Diterpene: A class of natural products composed of four isoprene units, often exhibiting bioactive properties including anticancer effects.
Apoptosis: Programmed cell death pathway characterised by nuclear condensation, DNA fragmentation and caspase activation.
Cytotoxicity: The capacity of a substance to cause damage or death to cells, commonly assessed in cancer cell lines.
Phase I enzymes: A group of metabolic enzymes (e.g. cytochrome P450s) that introduce reactive or polar groups into xenobiotics.
Phase II enzymes: Detoxification enzymes that conjugate metabolites to increase solubility and facilitate excretion, contributing to chemoprevention.
References
- The bioactivities of sclareol: A mini review. Frontiers in Pharmacology (2022).
- Tumour preventive potential of sclareol on 7, 12 dimethylbenz [a] anthracene (DMBA) induced hamster buccal pouch carcinogenesis. International Journal of Research in Pharmaceutical Sciences (2020).
- Anticancer potential of sclareol against human KB oral carcinoma cell line invitro. International Journal of Research in Pharmaceutical Sciences (2020).
About these summaries
This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.